One inescapable word dominated biomedicine this year: Ozempic.Physicians were amazed at the drug’s efficacy in treating diabetes, for which it is FDA approved, and...
Wearing an electrode-studded cap bristling with wires, a young man silently reads a sentence in his head. Moments later, a Siri-like voice breaks in,...
CRISPR has a problem: an embarrassment of riches.Ever since the gene editing system rocketed to fame, scientists have been looking for variants with better...
Our ability to manipulate the genes of living organisms has expanded dramatically in recent years. Now, researchers are a step closer to building genomes...
Senescent cells are biochemical waste factories.A new study suggests that a way to wipe them out is a medicine already approved for eye problems.
Dubbed...
Like many large pharmaceutical companies, Bristol Myers Squibb hasn’t made brain drugs a top priority over the last decade.
As a field, neuroscience represents a...
Food and Drug Administration scientists are scrutinizing whether an experimental gene editing therapy for sickle cell disease makes unwanted changes to DNA as part...
